Research Achievements

Obtained a number of independent patents

As an innovative enterprise deeply engaged in the field of controlled-release technology, GoeGoe Honglin Pharm. leverages keen market insights, continuous R&D investment, and technical support from a team of senior U.S. experts. We have mastered core technologies including controlled-release tablets, bilayer sustained-release tablets, sustained-release pellets, and enteric-coated pellets, covering multiple dosage forms such as compound and single-ingredient preparations, and has successfully obtained a number of independent patents covering core technologies and application scenarios.

JUPOPINE^® (Nifedipine Controlled-Release Tablets), which is one of our company’s flagship products, initiated R&D in 2006. With technical support from ALZA Corporation, GoeGoe Honglin Pharm. upgraded its technologies to establish an independent R&D and patent platform, and successfully developed JUPOPINE^® (Nifedipine Controlled-Release Tablets) independently. Its core technologies have been granted national patent protection—namely, the "Nifedipine Controlled-Release Tablets and Its Preparation Method" and "Drug Core Composition for Controlled-Release Drug Delivery"—providing clear evidence that GoeGoe Honglin Pharm. already possessed mature controlled-release technology in its early stages.
Similarly, ROTOFIER^® (Glipizide Extended Release Tablets), a well-established product with over a decade of market presence, has also obtained national patent protection for its core technologies (Glipizide Extended Release Tablets and Its Preparation Method, and Drug Core Composition for Controlled-Release Drug Delivery), further confirming the maturity of GoeGoe Honglin Pharm.’s controlled-release technology.

Osmotic pump controlled release technology

In summary, GoeGoe Honglin Pharm. maintains an industry-leading position in osmotic pump controlled release technology and is capable of independently developing preparations that achieve near zero-order drug release. Our products have obtained national recognition, stood the test of the market, and gained wide trust from doctors and patients.